Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

OXYBUTYNIN CHLORIDE

All products: general benefit

Other products in the same Health Canada class (G04BD) — coverage varies; not interchangeable

  • Flavoxate (Urispas): not a benefit

Apo-Oxybutynin · DIN 02163543 · 5mg · tablet

General benefitMarketed · checked 2026-09-19
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Apo-Oxybutynin · DIN 02163543 Manufacturer: Apotex Inc.; listing date 1996-10-01 Health Canada: Marketed since 2022-01-25 · brand APO-OXYBUTYNIN · ATC G04BD04 OXYBUTYNIN · form Tablet · route Oral · ingredients OXYBUTYNIN CHLORIDE 5 MG · company Apotex inc · schedule Prescription
Check this DIN again · Health Canada product record

Apo-Oxybutynin: Formulary list price $0.0986/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.0986 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18355 · Verify on the e-Formulary ↗ (DIN 02163543)

Source record
DIN 02163543: Apo-Oxybutynin Raw flags: sec3=Y Item: 120800033; group id 209; item number 0380; lccId None; manufacturer id APX Source form: Tab; strength: 5mg Recorded listing: General benefit Source prices (unrounded): $0.0986; ministry $0.0986 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02163543 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18355
Interchangeable products
Ditropan · DIN 01924761 · not recorded Novo-Oxybutynin · DIN 02230394 · $0.0986 PMS-Oxybutynin · DIN 02240550 · $0.0986
Shortage status: not checked (no credentials)
Other drugs in the same formulary class (12:08 Parasympatholytic (Cholinergic Blocking) Agents) and how they are covered

Matched class: 12:08 Parasympatholytic (Cholinergic Blocking) Agents

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: ACLIDINIUM BROMIDE, BENZTROPINE MESYLATE, ETHOPROPAZINE HCL, GLYCOPYRRONIUM BROMIDE, PROCYCLIDINE HCL, TIOTROPIUM BROMIDE MONOHYDRATE, UMECLIDINIUM Some products covered without a code (check the product listing): IPRATROPIUM BROMIDE, TRIHEXYPHENIDYL HCL 12:08 Parasympatholytic (Cholinergic Blocking) Agents

FLAVOXATE HCL

· 2 products · Listed, not a benefit · strengths: 200mg · Tab

ACLIDINIUM BROMIDE

· 1 products · General benefit · strengths: 400mcg/actuation · Pd Inh-60 Dose Pk

BENZTROPINE MESYLATE

· 1 products · General benefit · strengths: 1mg · Tab

ETHOPROPAZINE HCL

· 1 products · General benefit · strengths: 50mg · Tab

GLYCOPYRRONIUM BROMIDE

· 1 products · General benefit · strengths: 50mcg · Inh Pd-Cap

IPRATROPIUM BROMIDE

· 12 products · Listed, not a benefit (3), Limited Use, codes 256, 257, 258, 259 (3), Limited Use, codes 265, 266, 267, 268 (4), General benefit (2) · strengths: 250mcg/mL, 125mcg/mL, 20mcg/Metered Dose · Inh Sol-20mL Pk, Inh Sol-2mL UDV Pk, Inh-200 Dose Pk

PROCYCLIDINE HCL

· 1 products · General benefit · strengths: 2.5mg · Tab

TRIHEXYPHENIDYL HCL

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 2mg, 5mg · Tab

HYOSCINE BUTYLBROMIDE

· 2 products · Limited Use, codes 481 · strengths: 10mg · Tab

IPRATROPIUM BROMIDE/SALBUTAMOL

· 3 products · Listed, not a benefit (1), Limited Use, codes 256, 257, 258, 259 (2) · strengths: 500mcg/2.5mg/2.5mL · Inh Sol-2.5mL Amp Pk

SCOPOLAMINE HYDROBROMIDE

· 4 products · Listed, not a benefit (2), Limited Use, codes 481 (2) · strengths: 0.4mg/mL, 0.6mg/mL · Inj Sol (Preservative Free)

TRIMEBUTINE MALEATE

· 6 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 100mg, 200mg · Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 12:08 and 5 more
Full class listing Related classes: 12:04 Parasympathomimetic (Cholinergic) Agents, 12:12 Sympathomimetic (Adrenergic) Agents, 12:20 Skeletal Muscle Relaxants Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATIONS AND CLINICAL USE APO-OXYBUTYNIN (oxybutynin chloride) is indicated for the relief of symptoms associated with voiding in patients with uninhibited neurogenic bladder and reflex neurogenic bladder (i.e. urgency, frequency, urinary leakage, urge incontinence, dysuria). Geriatrics (> 65 years of age): Clinical studies of oxybutynin chloride did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger patients. Other reported clinical experience has not identified differences in responses between healthy elderly and younger patients. Page 3 of 23 Pediatrics (< 5 years of age): The safety and effectiveness of oxybutynin chloride in pediatric patients under 5 years of age have not been established. https://pdf.hres.ca/dpd_pm/00064481.PDF PM date: January 24, 2022 Source product: APO-OXYBUTYNIN; DIN 02163543; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.